Company Data
Portage Biotech Inc.
Ticker
PRTG
Current Price
$4.81 2.56%
Market Cap
$5.0M
Price Target
Refer to Report
Volume
1.8K
52wk Range
$2.098 - $23.01
Overview
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.